Share Name Share Symbol Market Type Share ISIN Share Description
Avacta LSE:AVCT London Ordinary Share GB00BYYW9G87 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 24.30p 73,430 08:00:00
Bid Price Offer Price High Price Low Price Open Price
23.60p 25.00p 24.30p 24.30p 24.30p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.76 -10.39 -13.49 18.2

Avacta (AVCT) Latest News

More Avacta News
Avacta Takeover Rumours

Avacta (AVCT) Share Charts

1 Year Avacta Chart

1 Year Avacta Chart

1 Month Avacta Chart

1 Month Avacta Chart

Intraday Avacta Chart

Intraday Avacta Chart

Avacta (AVCT) Discussions and Chat

Avacta (AVCT) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
10:12:5223.908,3681,999.95O
09:51:4323.6012028.32O
08:20:4723.6524,9425,898.78O
07:37:1124.0040,0009,600.00O
View all Avacta trades in real-time

Avacta (AVCT) Top Chat Posts

DateSubject
18/10/2018
09:20
Avacta Daily Update: Avacta is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker AVCT. The last closing price for Avacta was 24.30p.
Avacta has a 4 week average price of 23.50p and a 12 week average price of 21.20p.
The 1 year high share price is 70p while the 1 year low share price is currently 21.20p.
There are currently 75,009,487 shares in issue and the average daily traded volume is 87,288 shares. The market capitalisation of Avacta is £18,227,305.34.
10/10/2018
19:37
lantanatony: More jam tomorrow stuff from Avacta. Once again no real disclosure on the deal detail but just enough to depress the share price!
20/8/2018
16:11
jaknife: Not sure why you think that the "support is clearly there"? The share price has dropped to find a price. That's not the same as "support".
20/8/2018
09:21
dave4545: Vendors from the placing. They will have made a profit selling some but will take a hit now on others to get their funds to move on and fund the next placing. Not every share price stays above the placing price. They have dropped this on tiny volumes so when the overhang does clear it will shoot up again, all depends on how low it goes first.
15/8/2018
15:00
1i1i1i: At the moment yes, but with bundles of cash in the bank and all the exciting news due then I can only see one direction for the share price here.
15/8/2018
14:21
jaknife: But the share price is going downwards, not upwards?
30/7/2018
23:57
escapetohome: A disappointing share price performance Avacta. If you keep this all your bod may be wishing they had read about sustainable financing. Desparate times. Poor confidence in Avacta. A scrounger off shareholders rather than a deliverer of value. FIX IT . AND SOON.
14/5/2018
21:06
escapetohome: Come on now avacta this is silly, what does this sort of share price say about the running of the company?? Not good. I would get it sorted. Thats my very strong advice indeed. Nudge Nudge Wink Wink!!!!
29/3/2018
09:42
lantanatony: We need some proper Brokers,capable of supporting the share price. Let's also hope IP Group are the seller as we need them to reduce their influence. But most of all we need a deal with revenue attached.
18/3/2018
22:13
lantanatony: You may think,that I keep going about the Avacta brokers. But let me point out once again that when they were appointed,Avacta shares were around one pound. Furthermore,as market makers they seem happy to preside over any dramatic drop in the share price ,even on the sale of just a small amount of shares. Yet their Analysts are still predicting a Two pound share price! Talk about a "Toffee shop ". No that's unfair on Toffee Shops! Meanwhile,Avacta keep announcing hopeful information,but no meaningful revenue streams to support them. How could anyone realistically believe that this is a company capable of clinical drug development? Watch out for IP Group loading up Avacta with their next best idea. Then another speculative fundraising. Unfortunately,it's a very sad story. The Avacta Board need to examin their Corporate responsibility. You can not keep telling shareholders that you are going into clinical Development without a creditable structure and of course the finance.......can you?
08/11/2017
20:54
lantanatony: No support from for the share price from the market or our Brokers even at this low share price. Meanwhile, there seems to be at least one substantial seller about. Therefore, what is the point of our CEO presenting at a Finncap event this month when the hosts are not convinced? I have to ask, what party is insisting on the confidentiality in the deals that Avacta have published? Could it be Avacta are wanting to hide from the deal detail?! Can the whole Big Pharma investing sector be wrong to ignore Avacta? The share price says it all.
Avacta share price data is direct from the London Stock Exchange
add chat code
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20181018 14:14:17